IMMUNICUM AB
Summary
Immunicum is establishing a unique immuno-oncology approach through the development of allogeneic, off-the-shelf cell-based therapies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 54 M
Avg. Deal Size£ 54 M
All rights reserved. Copyright © 2025 Datasite
